Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Newscape launches third specialist UCITS fund

Monday, November 26, 2012
Opalesque Industry Update - Newscape Capital Group, the London based investment firm, has launched its third specialist UCITS Fund, its second launch in as many months. The Newscape Dynamic Rates and Currency Fund will target an annualised return of 12‐15% with annualised volatility expected to be around10%. The Fund will invest in the currencies and interest rates of OECD countries and is UCITS approved with daily liquidity, offered in Euro, GBP, Swiss Franc and US Dollar share classes.

While many investors have a large exposure to fixed income and equity asset classes, few have any capital committed to active investment in the largest market in the world – currencies. The Newscape Dynamic Rates and Currency Fund will offer investors the opportunity to access this attractive market in an extremely liquid and regulated format.

Stephen Decani, Newscape CEO commented, “the currency market is the largest market in the world with daily turnover in excess of US $5 trillion, more than 5x the average daily volume of the US bond market or over 25x the value of the average daily volume of the US equity market. Philippe has spent over three years developing the quantitative strategy and models behind the fund and we are excited to be launching it to the market.”

Philippe Bonnefoy, the lead manager of the Fund and Newscape’s Chairman & CIO, commented, “The currency market offers an exciting investment proposition as the majority of participants are not profit seeking. Central banks, sovereign wealth reserve managers, financial institutions, importers, exporters and consumers primarily use the market to hedge or settle financial transactions. This creates many opportunities for those investors seeking to gain from these inefficiencies. Through a detailed analytical process the Fund uses proprietary quantitative models to identify investable opportunities that have the highest probability of generating excellent risk‐adjusted return. The quantitative models identify trend, breakout, mean‐reversion and general structural mispricing."

Press release

bc

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for